Related Experiment Video
Updated: Apr 27, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Prevention of thromboembolic complication in atrial fibrillation by using anticoagulants
Insights
Warfarin significantly reduces stroke risk in adults with atrial fibrillation (AF). This study found fewer strokes in AF patients taking warfarin compared to those not on the medication.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia.
- AF increases the risk of thromboembolic events, including stroke.
- AF can manifest as paroxysmal or permanent conditions.
Purpose of the Study:
- To evaluate the efficacy of warfarin in mitigating stroke incidence among atrial fibrillation patients.
- Assessing the protective effect of warfarin against stroke in a clinical setting.
Main Methods:
- A hospital-based case study was conducted.
- The study included 50 patients diagnosed with atrial fibrillation.
- Data was collected between October 2009 and September 2011.
Main Results:
- Out of 50 patients, 10 developed stroke.
- None of the patients who developed stroke were on warfarin.
- 32 patients on warfarin did not experience a stroke.
Conclusions:
- Warfarin demonstrates significant effectiveness in reducing stroke incidence in patients with atrial fibrillation.
- The findings support the use of warfarin for stroke prevention in AF management.
Introduction:
Atrial fibrillation is the most common type of arrhythmia in adults. Atrial fibrillation occurs as paroxysms or may become established as permanent condition. Patients with atrial fibrillation are at increased risk for thromboembolic disease.
Aims And Objectives:
To study effectiveness of Warfarin in reducing Stroke incidence in patients of Atrial Fibrillation.
Material And Methods:
This hospital based case study was performed on 50 patients in Dr DY Patil Medical College and Research Centre from October 2009 to September 2011.
Results:
Out of 50, 10 patients developed stroke which were not on Warfarin and 32 patients didn't develop stroke who were on warfarin.
Conclusion:
Warfarin significantly reduces incidence of stroke in AF patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management

